Current status of first-line treatment of metastatic pancreatic cancer

被引：0
|
作者：
Ozaka, Masato [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Hepatobiliary Pancreat Med Dept, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY14-2
引用
收藏
页码：S1363 / S1363
页数：1
相关论文
共 50 条
  • [1] First-Line Treatment of Metastatic Pancreatic Cancer
    Tokh, Mohammed
    Bathini, Venu
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2012, 13 (02): : 159 - 162
  • [2] Updates on First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
    Strimpakos, Alexios S.
    Syrigos, Kostas N.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2011, 12 (04): : 339 - 342
  • [3] Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer
    Attard, C. L.
    Brown, S.
    Alloul, K.
    Moore, M. J.
    CURRENT ONCOLOGY, 2014, 21 (01) : E41 - E51
  • [4] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12
  • [5] First-Line Treatment for Advanced Pancreatic Cancer
    Oberstein, Paul E.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2011, 12 (02): : 96 - 100
  • [6] The First-Line Treatment for Advanced Pancreatic Cancer
    Merl, Man Yee
    Li, Jia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 148 - 150
  • [7] Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
    Gharaibeh, Mahdi
    McBride, Ali
    Alberts, David S.
    Slack, Marion
    Erstad, Brian
    Alsaid, Nimer
    Bootman, J. Lyle
    Abraham, Ivo
    PHARMACOECONOMICS, 2018, 36 (10) : 1273 - 1284
  • [8] Identification of aneuploidy biomarkers associated with response to first-line treatment of metastatic pancreatic cancer
    Chen, Kuei-Ting
    Sharaf, Radwa
    Frampton, Garrett
    Albacker, Lee
    Ebot, Ericka
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
    Mahdi Gharaibeh
    Ali McBride
    David S. Alberts
    Brian Erstad
    Marion Slack
    Nimer Alsaid
    J. Lyle Bootman
    Ivo Abraham
    PharmacoEconomics, 2018, 36 : 1333 - 1343
  • [10] Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
    Gharaibeh, Mahdi
    McBride, Ali
    Alberts, David S.
    Erstad, Brian
    Slack, Marion
    Alsaid, Nimer
    Bootman, J. Lyle
    Abraham, Ivo
    PHARMACOECONOMICS, 2018, 36 (11) : 1333 - 1343
12345